NORTH AMERICA EPILEPSY DEVICES MARKET FORECAST 2022-2030
TABLE
OF CONTENTS
1. RESEARCH
SCOPE & METHODOLOGY
1.1. STUDY
OBJECTIVES
1.2. SCOPE
OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS
& LIMITATIONS
2. EXECUTIVE
SUMMARY
2.1. MARKET
SIZE & ESTIMATES
2.2. MARKET
OVERVIEW
3. MARKET
DYNAMICS
3.1. KEY
DRIVERS
3.1.1. SOARING
OCCURRENCES OF EPILEPSY NORTH AMERICALY
3.1.2. ONSET
OF EPILEPSY IN ELDERLY PEOPLE
3.1.3. MITIGATION
OF EPILEPSY USING EARLY DIAGNOSIS
3.1.4. SURGE
IN POST-TRAUMATIC EPILEPSY WITH RISING BRAIN INJURY CASES
3.2. KEY
RESTRAINTS
3.2.1. MISPERCEPTIONS
AND MISINFORMATION ABOUT EPILEPSY
3.2.2. SHORTAGE
OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
4. KEY
ANALYTICS
4.1. IMPACT
OF COVID-19 ON EPILEPSY DEVICES MARKET
4.2. KEY
MARKET TRENDS
4.3. PORTER’S
FIVE FORCES ANALYSIS
4.3.1. BUYERS
POWER
4.3.2. SUPPLIERS
POWER
4.3.3. SUBSTITUTION
4.3.4. NEW
ENTRANTS
4.3.5. INDUSTRY
RIVALRY
4.4. OPPORTUNITY
MATRIX
4.5. VENDOR
LANDSCAPE
4.6. VALUE
CHAIN ANALYSIS
4.7. KEY
BUYING CRITERIA
4.7.1. COMFORT
& USABILITY
4.7.2. PRODUCT
FEATURES
4.7.3. CONFIDENTIALITY
4.8. REGULATORY
FRAMEWORK
5.1. CONVENTIONAL
DEVICES
5.2. WEARABLE
DEVICES
5.2.1. WATCHES
5.2.2. BRACELETS
5.2.3. CAMERA
DEVICES
5.2.4. MATTRESS
DEVICES
5.2.5. ANTI-SUFFOCATION
PILLOWS
5.2.6. OTHER
WEARABLE DEVICES
5.3. IMPLANTABLE
DEVICES
6. MARKET
BY TECHNOLOGY
6.1. VAGUS
NERVE STIMULATION
6.2. DEEP
BRAIN STIMULATION
6.2.1. MOVEMENT
DISORDERS
6.2.2. EPILEPSY
6.3. ACCELEROMETRY
6.4. RESPONSIVE
NEUROSTIMULATION
7. MARKET
BY DETECTION & PREDICTION DEVICES TYPE
7.1. ELECTROENCEPHALOGRAM
7.2. INTRACRANIAL
EEG
7.3. SURFACE
ELECTROMYOGRAPHY
7.4. ELECTROCARDIOGRAPHY
7.5. VIDEO
DETECTION SYSTEMS
7.6. ELECTRODERMAL
ACTIVITY
7.7. IMPLANTED
ADVISORY SYSTEMS
7.8. OTHER
DETECTION & PREDICTION DEVICE TYPES
8. MARKET
BY END-USER
8.1. HOSPITALS
& CLINICS
8.2. NEUROLOGY
CENTERS
8.3. HOME
CARE SETTINGS
8.4. OTHER
END-USERS
9. GEOGRAPHICAL
ANALYSIS
9.1. NORTH
AMERICA
9.1.1. MARKET
SIZE & ESTIMATES
9.1.2. KEY
GROWTH ENABLERS
9.1.3. KEY
CHALLENGES
9.1.4. KEY
PLAYERS
9.1.5. COUNTRY
ANALYSIS
9.1.5.1. UNITED
STATES
9.1.5.2. CANADA
10. COMPETITIVE
LANDSCAPE
10.1. KEY
STRATEGIC DEVELOPMENTS
10.1.1. ACQUISITIONS
10.1.2. PRODUCT
LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS
10.2. COMPANY
PROFILES
10.2.1. BOSTON
SCIENTIFIC CORPORATION
10.2.2. CADWELL
INDUSTRIES INC
10.2.3. COMPUMEDICS
LIMITED
10.2.4. DRÄGERWERK
AG & CO KGAA
10.2.5. EMPATICA
INC
10.2.6. KONINKLIJKE
PHILIPS NV
10.2.7. LIVANOVA
PLC
10.2.8. MEDTRONIC
PLC
10.2.9. NATUS
MEDICAL INCORPORATED
10.2.10. NEUROPACE
INC
10.2.11. NEUROSOFT
10.2.12. NIHON
KOHDEN CORPORATION
10.2.13. SHENZHEN
MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
LIST
OF TABLES
TABLE
1: NORTH AMERICA MARKET SNAPSHOT – EPILEPSY DEVICES
TABLE
2: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE
3: EXAMPLES OF MOBILE EEG DEVICES
TABLE
4: REGULATORY FRAMEWORK
TABLE
5: NORTH AMERICA EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS,
2018-2021 (IN $ MILLION)
TABLE
6: NORTH AMERICA EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, FORECAST YEARS,
2022-2030 (IN $ MILLION)
TABLE
7: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, HISTORICAL
YEARS, 2018-2021 (IN $ MILLION)
TABLE
8: NORTH AMERICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, FORECAST YEARS,
2022-2030 (IN $ MILLION)
TABLE
9: NORTH AMERICA EPILEPSY DEVICES MARKET, BY TECHNOLOGY, HISTORICAL YEARS,
2018-2021 (IN $ MILLION)
TABLE
10: NORTH AMERICA EPILEPSY DEVICES MARKET, BY TECHNOLOGY, FORECAST YEARS,
2022-2030 (IN $ MILLION)
TABLE
11: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION,
HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE
12: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, FORECAST
YEARS, 2022-2030 (IN $ MILLION)
TABLE
13: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION
DEVICES TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE
14: NORTH AMERICA EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION
DEVICES TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE
15: NORTH AMERICA EPILEPSY DEVICES MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021
(IN $ MILLION)
TABLE
16: NORTH AMERICA EPILEPSY DEVICES MARKET, BY END-USER, FORECAST YEARS,
2022-2030 (IN $ MILLION)
TABLE
17: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS,
2018-2021 (IN $ MILLION)
TABLE
18: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS,
2022-2030 (IN $ MILLION)
TABLE
19: LEADING PLAYERS OPERATING IN NORTH AMERICA EPILEPSY DEVICES MARKET
TABLE
20: LIST OF ACQUISITIONS
TABLE
21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE
22: LIST OF PARTNERSHIPS
LIST
OF FIGURES
FIGURE 1: KEY MARKET
TRENDS
FIGURE 2: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 3: OPPORTUNITY
MATRIX
FIGURE 4: VENDOR
LANDSCAPE
FIGURE 5: VALUE CHAIN
ANALYSIS
FIGURE 6: KEY BUYING
CRITERIA
FIGURE 7: NORTH AMERICA
EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
FIGURE 8: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY CONVENTIONAL DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 10: NORTH
AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY WEARABLE DEVICES, IN 2021
FIGURE 11: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2030 (IN $ MILLION)
FIGURE 12: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2030 (IN $ MILLION)
FIGURE 13: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 14: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 15: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2030 (IN $
MILLION)
FIGURE 16: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2030 (IN $
MILLION)
FIGURE 17: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 18: NORTH
AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
FIGURE 19: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2030 (IN $
MILLION)
FIGURE 20: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2030 (IN $
MILLION)
FIGURE 21: NORTH
AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DEEP BRAIN STIMULATION,
IN 2021
FIGURE 22: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2030 (IN $
MILLION)
FIGURE 23: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2030 (IN $ MILLION)
FIGURE 24: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY ACCELEROMETRY, 2022-2030 (IN $ MILLION)
FIGURE 25: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2030 (IN
$ MILLION)
FIGURE 26: NORTH
AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DETECTION &
PREDICTION DEVICES TYPE, IN 2021
FIGURE 27: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2030 (IN $
MILLION)
FIGURE 28: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2030 (IN $ MILLION)
FIGURE 29: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2030 (IN $
MILLION)
FIGURE 30: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2030 (IN $
MILLION)
FIGURE 31: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2030 (IN $
MILLION)
FIGURE 32: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2030 (IN $
MILLION)
FIGURE 33: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2030 (IN $
MILLION)
FIGURE 34: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY OTHER DETECTION & PREDICTION DEVICE
TYPES, 2022-2030 (IN $ MILLION)
FIGURE 35: NORTH
AMERICA EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
FIGURE 36: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $
MILLION)
FIGURE 37: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2030 (IN $ MILLION)
FIGURE 38: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, 2022-2030 (IN $
MILLION)
FIGURE 39: NORTH
AMERICA EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)
FIGURE 40: NORTH
AMERICA EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 41: UNITED
STATES EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 42: CANADA
EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
KEY
FINDINGS
The North America
epilepsy devices market is predicted to increase with an 8.01% CAGR by the end
of the forecast period, 2022-2030. The
key players in the region are spending extensively on the research and
development of new products, getting new product approvals, and innovating
technologies, driving the market growth.
Get more Insights into
the North America Epilepsy Devices
Market:
https://inkwoodresearch.com/reports/north-america-epilepsy-devices-market/
MARKET
INSIGHTS
The North America
epilepsy devices market growth assessment includes the evaluation of the United
States and Canada. According to the Canadian Epilepsy Alliance, there are
around 260,000 epileptics in Canada. 78,000 of them, or 30%, have
drug-resistant epilepsy. Canada’s healthcare system is funded by public and
private sectors, primarily private insurance and out-of-pocket expenses.
Spending on public health care in Canada has increased and is anticipated to
support market expansion. The population of Canada has increased, and
decision-makers in the health system must consider the effects of this growth
on the prospective demand for healthcare services in the future.
The greatest
demographic segment in recent Canadian history is reaching 65. The consensus is
that an aging population would result in higher demands for medical services
and a faster pace of increase in health spending. Hospitals in Canada now have
more installed and operational computed tomography (CT) and magnetic resonance
imaging (MRI) machines. The capacity of medical imaging technologies to
identify more anomalies has expanded hospital services.
COMPETITIVE
INSIGHTS
Leading companies
operating in the market include Cadwell Industries Inc, Empatica Inc, etc.
Our
report offerings include:
· Explore
key findings of the overall market
· Strategic
breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
· Market
forecasts for a minimum of 9 years, along with 3
years of historical data for all segments, sub-segments, and regions
· Market
Segmentation caters to a thorough assessment of key
segments with their market estimations
· Geographical
Analysis: Assessments of the mentioned regions and country-level segments with their market share
· Key
analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix,
Key Buying Criteria, etc.
· Competitive
landscape is the theoretical explanation of the key companies based on factors,
market share, etc.
· Company
profiling: A detailed company overview, product/services offered, SCOT analysis,
and recent strategic developments
SEGMENTATION
1. BOSTON
SCIENTIFIC CORPORATION
2. CADWELL
INDUSTRIES INC
3. COMPUMEDICS
LIMITED
4. DRÄGERWERK
AG & CO KGAA
5. EMPATICA
INC
6. KONINKLIJKE
PHILIPS NV
7. LIVANOVA
PLC
8. MEDTRONIC
PLC
9. NATUS
MEDICAL INCORPORATED
10. NEUROPACE
INC
11. NEUROSOFT
12. NIHON
KOHDEN CORPORATION
13. SHENZHEN
MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
Comments
Post a Comment